Healthcare provider profile · identity verified

Olga Filipova, M.D.

Internal Medicine · BROOKLYN, NY · NPI 1164588554

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	97
Albuterol Sulfate Hfa	Albuterol Sulfate	325	51
Famotidine	Famotidine	256	50
Omeprazole	Omeprazole	198	40
Jardiance	Empagliflozin	196	35
Gabapentin	Gabapentin	190	42
Diclofenac Sodium	Diclofenac Sodium	187	45
Amlodipine Besylate	Amlodipine Besylate	185	44
Ozempic	Semaglutide	173	33
Levothyroxine Sodium	Levothyroxine Sodium	157	29
Metformin Hcl	Metformin Hcl	153	34
Furosemide	Furosemide	140	28
Pantoprazole Sodium	Pantoprazole Sodium	139	20
Rosuvastatin Calcium	Rosuvastatin Calcium	135	39
Linzess	Linaclotide	127	23
Tamsulosin Hcl	Tamsulosin Hcl	127	29
Losartan Potassium	Losartan Potassium	122	27
Montelukast Sodium	Montelukast Sodium	108	21
Metformin Hcl Er	Metformin Hcl	104	28
Metoprolol Succinate	Metoprolol Succinate	102	27
Carvedilol	Carvedilol	97	13
Breo Ellipta	Fluticasone/Vilanterol	94	16
Duloxetine Hcl	Duloxetine Hcl	90	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	21
Celecoxib	Celecoxib	85	34
Pravastatin Sodium	Pravastatin Sodium	84	15
Metoprolol Tartrate	Metoprolol Tartrate	77	19
Eliquis	Apixaban	76	17
Simvastatin	Simvastatin	76	15
Januvia	Sitagliptin Phosphate	75	13
Fluticasone Propionate	Fluticasone Propionate	73	18
Ezetimibe	Ezetimibe	70	13
Lisinopril	Lisinopril	70	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	68	suppressed
Finasteride	Finasteride	67	15
Enalapril Maleate	Enalapril Maleate	64	13
Pregabalin	Pregabalin	64	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	15
Alendronate Sodium	Alendronate Sodium	61	15
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	61	17
Clopidogrel	Clopidogrel Bisulfate	60	14
Vascepa	Icosapent Ethyl	60	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	11
Mirtazapine	Mirtazapine	51	12
Ketoconazole	Ketoconazole	50	11
Hydrochlorothiazide	Hydrochlorothiazide	48	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Trulicity	Dulaglutide	43	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Trazodone Hcl	Trazodone Hcl	41	12
Myrbetriq	Mirabegron	36	suppressed
Labetalol Hcl	Labetalol Hcl	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Lactulose	Lactulose	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	33	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Synjardy	Empagliflozin/Metformin Hcl	27	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	11
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Zenpep	Lipase/Protease/Amylase	25	suppressed
Baclofen	Baclofen	24	suppressed
Lidocaine	Lidocaine	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Xifaxan	Rifaximin	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Invokamet Xr	Canagliflozin/Metformin Hcl	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Topiramate	Topiramate	19	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Anastrozole	Anastrozole	16	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Zileuton Er	Zileuton	16	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Risperidone	Risperidone	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Halobetasol Propionate	Halobetasol Propionate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error